The activity will allow learners to consider the practical implications of advances in assessing progression in MS. Featuring two experts in multiple sclerosis, the activity will provide a focused overview of the mechanisms underlying disease progression in the absence of relapses in people with MS, followed by a discussion of current and emerging approaches to characterise disease progression and how to apply these approaches in practice.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Address:
- Masdijk 409
Pricing
$54 – $4,128 per course
typical $950 · based on 60 courses listed here
Collected from the provider’s public pages · source
Specialties served/covered
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Foot & Ankle Surgery
- Gastroenterology
- General Internal Medicine
- General Pediatrics
- Head & Neck Surgery
- Interventional Radiology
- Medical Oncology
- Nephrology
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Pediatric Radiology
- Physical Medicine & Rehabilitation
- Pulmonary Disease
- Radiation Oncology
- Rheumatology
- Urological Oncology
- Vascular Neurology
- Vascular Surgery
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pediatrics
- Radiology
- Rehabilitation
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Case-based learning
- Credit · Up to 0.5 credits
- Commercial Support
-
Available fromNov 2, 2026
-
Last day to claim creditNov 2, 2027 1 year left
-
PRIME Education, Inc. (PRIME®) Collaborative Approaches to Detecting and Addressing Silent Disease Progression in Multiple Sclerosis
-
PVI, PeerView Institute for Medical Education Quiet Progression, Loud Impact: Expert Insights on the Role of BTK Inhibitors Beyond Relapse in MS
-
DrBeen Corp Atherosclerosis Progression – Clinical Horizon
-
PeerVoice, Siyemi Europe Limited PeerVoice – What s Now and What s Next: The Evolving Treatment Landscape for Progressive MS
-
PeerVoice, Siyemi Europe Limited PeerVoice – Navigating the Changing Landscape of mCRPC Management: Reviewing Roads Travelled and Exploring Emerging Directions – Enduring
-
PeerVoice, Siyemi Europe Limited PeerVoice – Beyond the Virus: New Strategies to Improve Outcomes of Non-HPV Associated Recurrent/Metastatic Head and Neck Cancer – Enduring
